肺ドラッグデリバリーデバイス市場：製品タイプ、用途、流通チャネル別-2025-2030年世界予測

肺ドラッグデリバリーデバイス市場は、2023年に500億7,000万米ドルと評価され、2024年には529億9,000万米ドルに達すると予測され、CAGR 5.91％で成長し、2030年には748億8,000万米ドルになると予測されています。

肺ドラッグデリバリーデバイスは、喘息、慢性閉塞性肺疾患（COPD）、その他の肺疾患のような呼吸器疾患に対して、薬剤を肺に直接送達し、迅速な作用発現を提供するように設計された特殊なシステムです。これらのデバイスは、肺の局所的な薬物濃度を高めながら、全身的な副作用を最小限に抑え、標的療法を提供するために不可欠です。応用範囲はネブライザー、定量吸入器（MDI）、ドライパウダー吸入器（DPI）を含み、最終用途は主に慢性呼吸器疾患患者、ヘルスケア施設、在宅ケア環境です。この市場は、呼吸器疾患の有病率の上昇、環境汚染の増加、呼吸器疾患にかかりやすい世界人口の高齢化などが成長の原動力となっています。さらに、接続性とデータ分析を提供するスマート吸入器などの技術的進歩は、患者のアドヒアランスと転帰の改善に多大な機会を提供します。しかし、高い開発コスト、厳しい規制承認、ジェネリック製品との競合などの課題によって成長が妨げられる可能性があります。また、発展途上地域における認知度の低さや購入しやすさの問題も、拡大の妨げとなっています。企業にとっては、より効率的で費用対効果が高く、使いやすい機器を開発するために研究開発に投資することが差別化につながります。また、IoT対応機能を取り入れたり、より効率的な肺デリバリーのための新規薬剤製剤を研究したりすることで、新たな道を切り開くこともできます。地域的には、呼吸器疾患の発生率が急速に増加している新興市場でのプレゼンスを拡大することで、より高い成長の可能性が期待できます。さらに、ヘルスケアプロバイダーと提携し、肺送達デバイスの利点や使用方法に関する教育プログラムを実施することで、ユーザーのためらいを克服し、採用率を向上させることができます。このように肺ドラッグデリバリー市場は、有望な機会と内在する課題のバランスを提示しており、戦略的イノベーションと的を絞った市場拡大努力が必要です。

市場力学：急速に進化する肺ドラッグデリバリーデバイス市場の主要市場インサイトを公開

肺ドラッグデリバリーデバイス市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 慢性呼吸器疾患の世界の増加
  • デジタルまたはスマート吸入器開発の利用急増
  • 代替ルートとしての肺ドラッグデリバリーデバイスへのシフトの増加
• 市場抑制要因
  • 価格と規制に関する問題
• 市場機会
  • 肺用デバイスにおける新たな技術進歩
  • 治療機器に対するヘルスケア支出の増加
• 市場の課題
  • エアロゾル化粒子の沈着によるメンテナンスの難しさ

ポーターの5つの力：肺ドラッグデリバリーデバイス市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、肺ドラッグデリバリーデバイス市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：肺ドラッグデリバリーデバイス市場における外部からの影響の把握

外部マクロ環境要因は、肺ドラッグデリバリーデバイス市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析肺ドラッグデリバリーデバイス市場における競合情勢の把握

肺ドラッグデリバリーデバイス市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス肺ドラッグデリバリーデバイス市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、肺ドラッグデリバリーデバイス市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨肺ドラッグデリバリーデバイス市場における成功への道筋を描く

肺ドラッグデリバリーデバイス市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 慢性呼吸器疾患の発生率が世界的に上昇
    • デジタルまたはスマート吸入器の開発による使用の急増
    • 代替ルートとして肺ドラッグデリバリーデバイスへの移行が増加
  • 抑制要因
    • 価格と規制に関する問題
  • 機会
    • 肺デバイスにおける新たな技術的進歩
    • 治療機器に対するヘルスケア費の増加
  • 課題
    • エアロゾル粒子の堆積によるメンテナンスの困難
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 肺ドラッグデリバリーデバイス市場：製品タイプ別

• ドライパウダー吸入器
• 定量吸入器
• ネブライザー

第7章 肺ドラッグデリバリーデバイス市場：用途別

• 喘息
• 慢性閉塞性肺疾患
• 嚢胞性線維症

第8章 肺ドラッグデリバリーデバイス市場：流通チャネル別

• 病院薬局
• 小売薬局

第9章 南北アメリカの肺ドラッグデリバリーデバイス市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の肺ドラッグデリバリーデバイス市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの肺ドラッグデリバリーデバイス市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• 3M Company
• Adherium Limited
• Aerogen Ltd.
• AptarGroup, Inc.
• AstraZeneca PLC
• Boehringer Ingelheim International GmbH
• Celares GmbH
• Cipla Inc.
• Gilbert Technologies BV
• GlaxoSmithKline PLC
• Koninklijke Philips N.V.
• MannKind Corporation
• Novartis AG
• Omron Corporation
• Sunovion Pharmaceuticals Inc.

LIST OF FIGURES

• FIGURE 1. PULMONARY DRUG DELIVERY DEVICES MARKET RESEARCH PROCESS
• FIGURE 2. PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. PULMONARY DRUG DELIVERY DEVICES MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. PULMONARY DRUG DELIVERY DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. PULMONARY DRUG DELIVERY DEVICES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. PULMONARY DRUG DELIVERY DEVICES MARKET DYNAMICS
• TABLE 7. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRY POWDER INHALER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY METERED DOSE INHALER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY ASTHMA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COPD, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY CYSTIC FIBROSIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY RETAIL PHARMACY STORES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 22. ARGENTINA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 23. ARGENTINA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 24. ARGENTINA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 25. BRAZIL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 26. BRAZIL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 27. BRAZIL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 28. CANADA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 29. CANADA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 30. CANADA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 31. MEXICO PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 32. MEXICO PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 33. MEXICO PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 34. UNITED STATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 35. UNITED STATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 37. UNITED STATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 38. ASIA-PACIFIC PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 39. ASIA-PACIFIC PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 42. AUSTRALIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 43. AUSTRALIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 44. AUSTRALIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 45. CHINA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 46. CHINA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 47. CHINA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 48. INDIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 49. INDIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 50. INDIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 51. INDONESIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 52. INDONESIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 53. INDONESIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 54. JAPAN PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 55. JAPAN PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 56. JAPAN PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 57. MALAYSIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 58. MALAYSIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 59. MALAYSIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 60. PHILIPPINES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 61. PHILIPPINES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 62. PHILIPPINES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 63. SINGAPORE PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 64. SINGAPORE PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 65. SINGAPORE PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 66. SOUTH KOREA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 67. SOUTH KOREA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 68. SOUTH KOREA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 69. TAIWAN PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 70. TAIWAN PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 71. TAIWAN PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 72. THAILAND PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 73. THAILAND PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 74. THAILAND PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 75. VIETNAM PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 76. VIETNAM PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 77. VIETNAM PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 78. EUROPE, MIDDLE EAST & AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 79. EUROPE, MIDDLE EAST & AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 82. DENMARK PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 83. DENMARK PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 84. DENMARK PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 85. EGYPT PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 86. EGYPT PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 87. EGYPT PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 88. FINLAND PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 89. FINLAND PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 90. FINLAND PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 91. FRANCE PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 92. FRANCE PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 93. FRANCE PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 94. GERMANY PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 95. GERMANY PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 96. GERMANY PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 97. ISRAEL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 98. ISRAEL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 99. ISRAEL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 100. ITALY PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 101. ITALY PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 102. ITALY PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 103. NETHERLANDS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 104. NETHERLANDS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 105. NETHERLANDS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 106. NIGERIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 107. NIGERIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 108. NIGERIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 109. NORWAY PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 110. NORWAY PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 111. NORWAY PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 112. POLAND PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 113. POLAND PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 114. POLAND PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 115. QATAR PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 116. QATAR PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 117. QATAR PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 118. RUSSIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 119. RUSSIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 120. RUSSIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 121. SAUDI ARABIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 122. SAUDI ARABIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 123. SAUDI ARABIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 124. SOUTH AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 127. SPAIN PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 128. SPAIN PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 129. SPAIN PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 130. SWEDEN PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 131. SWEDEN PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 132. SWEDEN PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 133. SWITZERLAND PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 134. SWITZERLAND PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 135. SWITZERLAND PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 136. TURKEY PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 137. TURKEY PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 138. TURKEY PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 139. UNITED ARAB EMIRATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 140. UNITED ARAB EMIRATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 141. UNITED ARAB EMIRATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 142. UNITED KINGDOM PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 143. UNITED KINGDOM PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 144. UNITED KINGDOM PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 145. PULMONARY DRUG DELIVERY DEVICES MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 146. PULMONARY DRUG DELIVERY DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

The Pulmonary Drug Delivery Devices Market was valued at USD 50.07 billion in 2023, expected to reach USD 52.99 billion in 2024, and is projected to grow at a CAGR of 5.91%, to USD 74.88 billion by 2030.

Pulmonary drug delivery devices are specialized systems designed to deliver medications directly to the lungs, thus offering a rapid onset of action for respiratory conditions like asthma, chronic obstructive pulmonary disease (COPD), and other pulmonary disorders. These devices are essential as they provide targeted therapy, minimizing systemic side effects while enabling higher local drug concentrations in the lungs. The application scope encompasses nebulizers, metered-dose inhalers (MDIs), and dry powder inhalers (DPIs), with end-use predominantly among patients with chronic respiratory conditions, healthcare facilities, and home care settings. The market is poised for growth driven by rising prevalence of respiratory diseases, increasing environmental pollution, and an aging global population susceptible to respiratory issues. Furthermore, technological advancements such as smart inhalers, which provide connectivity and data analytics, offer tremendous opportunities for improvement in patient adherence and outcomes. However, growth can be hampered by challenges including high development costs, stringent regulatory approvals, and competition from generic products. Limited awareness and affordability issues in developing regions also constrain expansion. For businesses, investing in R&D to develop more efficient, cost-effective, and user-friendly devices can be a differentiator. Incorporating IoT-enabled features and exploring novel drug formulations for more efficient pulmonary delivery can also open new avenues. Geographically, expanding presence in emerging markets where the incidence of respiratory disorders is rapidly increasing could provide higher growth potential. Furthermore, partnerships with healthcare providers to implement educational programs on the benefits and usage of pulmonary delivery devices can help overcome user hesitancy and improve adoption rates. The pulmonary drug delivery market thus presents a balance of promising opportunities and inherent challenges, necessitating strategic innovation and targeted market expansion efforts.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Pulmonary Drug Delivery Devices Market

The Pulmonary Drug Delivery Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising incidence of chronic respiratory diseases globally
  • Surge in use of development of digital or smart inhalers
  • Increasing shift toward pulmonary drug delivery devices as alternate route
• Market Restraints
  • Issues concerned with price and regulations
• Market Opportunities
  • Emerging technological advancements in pulmonary devices
  • Increasing healthcare expenditure on therapeutic devices
• Market Challenges
  • Difficulty in maintenance due to deposition of aerosolized particles

Porter's Five Forces: A Strategic Tool for Navigating the Pulmonary Drug Delivery Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Pulmonary Drug Delivery Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Pulmonary Drug Delivery Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Pulmonary Drug Delivery Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Pulmonary Drug Delivery Devices Market

A detailed market share analysis in the Pulmonary Drug Delivery Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Pulmonary Drug Delivery Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Pulmonary Drug Delivery Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Pulmonary Drug Delivery Devices Market

A strategic analysis of the Pulmonary Drug Delivery Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Pulmonary Drug Delivery Devices Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Adherium Limited, Aerogen Ltd., AptarGroup, Inc., AstraZeneca PLC, Boehringer Ingelheim International GmbH, Celares GmbH, Cipla Inc., Gilbert Technologies BV, GlaxoSmithKline PLC, Koninklijke Philips N.V., MannKind Corporation, Novartis AG, Omron Corporation, and Sunovion Pharmaceuticals Inc..

Market Segmentation & Coverage

This research report categorizes the Pulmonary Drug Delivery Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product Type, market is studied across Dry Powder Inhaler, Metered Dose Inhaler, and Nebulizer.
• Based on Application, market is studied across Asthma, COPD, and Cystic Fibrosis.
• Based on Distribution Channel, market is studied across Hospital Pharmacies and Retail Pharmacy Stores.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising incidence of chronic respiratory diseases globally
    • 5.1.1.2. Surge in use of development of digital or smart inhalers
    • 5.1.1.3. Increasing shift toward pulmonary drug delivery devices as alternate route
  • 5.1.2. Restraints
    • 5.1.2.1. Issues concerned with price and regulations
  • 5.1.3. Opportunities
    • 5.1.3.1. Emerging technological advancements in pulmonary devices
    • 5.1.3.2. Increasing healthcare expenditure on therapeutic devices
  • 5.1.4. Challenges
    • 5.1.4.1. Difficulty in maintenance due to deposition of aerosolized particles
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Pulmonary Drug Delivery Devices Market, by Product Type

• 6.1. Introduction
• 6.2. Dry Powder Inhaler
• 6.3. Metered Dose Inhaler
• 6.4. Nebulizer

7. Pulmonary Drug Delivery Devices Market, by Application

• 7.1. Introduction
• 7.2. Asthma
• 7.3. COPD
• 7.4. Cystic Fibrosis

8. Pulmonary Drug Delivery Devices Market, by Distribution Channel

• 8.1. Introduction
• 8.2. Hospital Pharmacies
• 8.3. Retail Pharmacy Stores

9. Americas Pulmonary Drug Delivery Devices Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Pulmonary Drug Delivery Devices Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Pulmonary Drug Delivery Devices Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. 3M Company
• 2. Adherium Limited
• 3. Aerogen Ltd.
• 4. AptarGroup, Inc.
• 5. AstraZeneca PLC
• 6. Boehringer Ingelheim International GmbH
• 7. Celares GmbH
• 8. Cipla Inc.
• 9. Gilbert Technologies BV
• 10. GlaxoSmithKline PLC
• 11. Koninklijke Philips N.V.
• 12. MannKind Corporation
• 13. Novartis AG
• 14. Omron Corporation
• 15. Sunovion Pharmaceuticals Inc.